Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Prediction Market Investments Continue Despite Regulatory Uncertainty Financial Services Roundup Market Talks Highlight Experian SoFi Technologies and Sector Developments UK and Six Gulf States Sign 37B Trade Agreement Unlocking 580M in Tariff Savings UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister JPMorgans Summer Reading List for Affluent Clients Highlights AI Leadership and Unexpected Titles PXED Q1 2026 Earnings Strong EPS Beat Drives Stock Higher RCMT Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines Unifi Inc UFI Q1 2026 Earnings EPS Beat Provides Tailwind as Stock Gains Modestly Taoping Inc TAOP Q2 2011 Earnings EPS Misses Estimates Amid Challenging Quarter XENE Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues Scilex Holding Company SCLX Slips 068 as Shares Test Key Support Near 559 Wheeler Real Estate 700 Convertible Notes WHLRL Hold Steady at 8001 Amid Low Volume 1RT Acquisition Corp Units ONCHU Holds Steady at 1032 Amid Quiet Trading RiverNorth Managed Duration Municipal Income Fund RMM Advances 127 as Bond Markets Stabilize Plus500 Reports 11 Revenue Growth Reaffirms FullYear Guidance UK Energy Price Cap to Rise 13 from July 1 What Households Need to Know Polymarket Traders Bet SpaceX OpenAI Anthropic IPOs Could Top 14 Trillion in Market Cap Metas Zuckerberg Leaked Comment on AI Training Using Employee Data Raises Efficiency and Job Concerns AWK Q1 2026 Earnings EPS Misses Estimates as Shares Edge Higher Figure Technology Solutions Inc FIGR Q1 2026 Earnings EPS Misses Consensus Amid Market Headwinds Aon plc AON Q1 2026 Earnings EPS Beats Estimates as Stock Edges Lower XFOR Q1 2026 Earnings NarrowerThanExpected Loss Despite Flat Revenue MTB Q1 2026 Earnings Earnings Beat Estimates as Net Interest Income Holds Steady REVB Q1 2026 Earnings Staggering EPS Miss Highlights Ongoing Clinical Development Costs